about
Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East AsiaInterventions for visceral leishmaniasisRapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibodyWhole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistanceSerological tests for visceral leishmaniasisRecent developments and future prospects in the treatment of visceral leishmaniasisDevelopments in Diagnosis of Visceral Leishmaniasis in the Elimination EraStrategies to overcome antileishmanial drugs unresponsivenessCurrent challenges in treatment options for visceral leishmaniasis in India: a public health perspectiveFailure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemicCost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, IndiaSingle-dose liposomal amphotericin B for visceral leishmaniasis in IndiaTreatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip testTrial of oral miltefosine for visceral leishmaniasisAmphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasisTreatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trialReactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasisCost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinentInterferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept studyLeishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamstersDrug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasisMore efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effectsLeishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasisExperimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocolTreatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, IndiaImipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infectionCytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasisRole of efflux pumps and intracellular thiols in natural antimony resistant isolates of Leishmania donovaniOver-expression of 60s ribosomal L23a is associated with cellular proliferation in SAG resistant clinical isolates of Leishmania donovaniCharacterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasisAntimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune responseEfficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label studyArsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort studyOver-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovaniCombined Immune Therapy for the Treatment of Visceral LeishmaniasisEvolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinentMorphological and Genotypic Variations among the Species of the Subgenus Adlerius (Diptera: Psychodidae, Phlebotomus) in IranWho is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South AsiaComparative study on the tensile bond strength and marginal fit of complete veneer cast metal crowns using various luting agents: An in vitro study
P50
Q21132005-76CEE4CE-C4F7-4A43-8880-67B3AFE0E8E4Q24235182-7EB8EFEE-16BE-437F-8FE2-E3A7A0271B50Q24539199-1C5345DA-4FA3-4140-9E66-9A971194BD5AQ24633552-716F4F27-94EC-45B0-B9EC-5ED968CB635EQ24672136-42EB356E-DEE4-4175-8416-EBE19AA84D67Q26740563-7DB9DCC7-D4C7-48E4-A7A6-85A8A9F0EB55Q26769062-54396779-06D3-436E-8061-57745F423EC1Q26849297-59BFAC25-B775-4E7E-ACDA-1382D402A590Q28073426-CC6E1FA5-3356-43C2-B6CE-43D10AA48013Q28142100-75D497AC-4FF1-4776-89CF-2D7C823F87ACQ28250267-DACC85A6-7040-4A14-BB3C-1A1984D15DD2Q28272916-1EC96737-7336-4869-9CC3-4D1532BCDD01Q28283745-FF12ED80-0F06-4C88-9A70-F9DC547E214DQ28284965-C8920E4A-2938-468B-AA15-7E19755EAD7EQ28291213-DF6F6015-E7CC-4E9B-9A93-F50F81570A38Q28294683-3F8EFE2E-E637-475C-894C-84C861CF96DFQ28346660-637A15F7-B42F-463E-B9D2-A47468D2C553Q28367595-6A470BDF-CC28-4CD0-86F6-011213CEF1A6Q28475431-AF1709FA-78B5-45DF-ACD3-76189E2B81CBQ28477803-C98910B5-F05A-4387-8B4A-951EFBDAA981Q28480398-B81931E4-381A-4E04-8547-B5E0DE060884Q28483875-B8FC54D1-742C-426E-AEF1-00069C9C546BQ28483969-6516E390-9CE6-4067-B8F2-F4FF7098819AQ28483976-5A96BA98-6FDC-4BCF-8049-9AEEEC8D134DQ28483977-103D0026-20DD-4AAE-8F98-269066C994D9Q28484459-F26BEA17-B416-4307-8306-7EB342B0BC8FQ28484622-3050A317-1E64-403F-A2B9-0B3FA4331281Q28485121-734F3D49-0B85-4186-A241-B6C94D11DD16Q28533525-B83AEEE2-1188-4D0E-AB6E-502EEA9740C4Q28536134-48255735-0EAA-4CC0-B7FD-21CBE4352085Q28539119-B9743A5E-FAFD-4E0F-A479-D30FBE926383Q28540810-732EAC86-C3F4-45E3-AFEA-27305F9ACE1AQ28543060-DB491CAC-7091-4553-B21C-6D8AAA78D98FQ28543757-437106B6-4F10-413A-880E-C0A115A8FE53Q28547415-DA1A8164-F373-4024-89FD-7F8C3B2C457FQ28550162-10536D4D-4EDF-4A78-9571-ADDC091E4635Q28551055-8617BA21-BD98-46F8-BC51-8505D4E92860Q28647997-95AAA4D3-405A-4194-99E5-44311A0D0783Q28741732-C72710C7-0010-467A-8FE2-82EFC2797C79Q28821394-B1298E63-968E-47B4-AF73-9C5FE1FAA3F2
P50
name
Shyam Sundar
@ast
Shyam Sundar
@en
Shyam Sundar
@es
Shyam Sundar
@nl
type
label
Shyam Sundar
@ast
Shyam Sundar
@en
Shyam Sundar
@es
Shyam Sundar
@nl
prefLabel
Shyam Sundar
@ast
Shyam Sundar
@en
Shyam Sundar
@es
Shyam Sundar
@nl